Back to results
US 12,702,651 B2Granted
Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
AssigneeHarrow IP, LLC
InventorsJohn Scott Karolchyk, Mark L. Baum, Dennis Saadeh
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
Claims16
A method of rapidly dilating a subject's pupils, the method comprising:
- administering to the subject via intraocular injection a therapeutically effective amount of a composition consisting of:
- a therapeutically effective quantity of phenylephrine hydrochloride;
- a therapeutically effective quantity of tropicamide having a concentration in the composition of about 0.04% (w/v) to about 0.06% (w/v);
- at least one metal chelator;
- at least one anesthetic;
- optionally, at least one tonicity adjusting agent comprising one or more chloride salts selected from the group consisting of sodium chloride, potassium chloride, and magnesium chloride;
- optionally, hydrochloric acid and/or sodium hydroxide;
- at least one non-steroid anti-inflammatory drug;
- optionally, at least one excipient;
- and
- a quantity of sterile water,
- wherein the subject's pupils are dilated from a first diameter to a second diameter within one minute or less after administering the composition, wherein the difference between the first diameter and the second diameter is from about 5.0 mm to about 7.0 mm.
9 more elements
Dependencies are inferred from the claim text.